Japan Sarcopenia Treatment Market to 2032
Overview
The Japan Sarcopenia Treatment Market is expected to reach a 262.28 USD Million by 2032 and is projected to grow at a CAGR of 11.20% from 2025 to 2032.
Revenue, 2024 (USD Million)
143.53
Forecast, 2032 (USD Million)
262.28
CAGR, 2024 - 2032
11.20%
Report Coverage
Japan
Japan Sarcopenia Treatment Market 2018-2032 USD Million
Japan Sarcopenia Treatment Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 143.53 USD Million
- Projected Market Size (2032): 262.28 USD Million
- CAGR (2025-2032): 11.20%
Key Findings of Japan Sarcopenia Treatment Market
- The Japan Sarcopenia Treatment Market was valued at 143.53 USD Million in 2024.
- The Japan Sarcopenia Treatment Market is likely to grow at a CAGR of 11.20% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Direct Tender in Distribution Channel Segment accounted for the largest share of the market with a revenue of 103.25 USD Million
- The fastest growing segment Pre-Sarcopenia in Stages Segment grew Fastest with a CAGR of 12.44% during the forecast period from 2024 to 2032.
Japan Sarcopenia Treatment Market Scope
Japan Sarcopenia Treatment Market Segmentation & Scope
Treatment Type
- Others
- Medications1
- Vitamin/Dietary Supplements1
Type
- Secondary Sarcopenia
- Primary Sarcopenia
Distribution Channel
- Others
- Retail Sales
- Direct Tender
Stages
- Severe Sarcopenia
- Sarcopenia
- Pre-Sarcopenia
Route of Administration
- Others
- Injectables
- Oral
Gender
- Female
- Male
End User
- Others
- Home Healthcare
- Speciality Clinics
- Hospitals
Japan Sarcopenia Treatment Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 143.53 USD Million |
| Market Value in 2032 | 262.28 USD Million |
| CAGR (2025-2032) | 11.20% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Treatment Type,Type,Distribution Channel,Stages,Route of Administration,Gender,End User |
Regional Insights:
-
Leading Market (2024-2032): Japan, leading in terms of revenue 143.53 USD Million in 2024
- Key Country: Japan, leading in terms of revenue with value of 143.53 USD Million in 2024.
Segments and Scope
-
Japan Sarcopenia Treatment Market to 2032, By Treatment Type
- Vitamin/Dietary Supplements1 is the largest segment in Japan Sarcopenia Treatment Market to 2032 with a revenue of 76.49 USD Million in the year 2024.
- Vitamin/Dietary Supplements1 is the Fastest growing segment in Japan Sarcopenia Treatment Market to 2032 with a Growth rate of 11.97 % in forecast period 2025-2032.
-
Japan Sarcopenia Treatment Market to 2032, By Type
- Primary Sarcopenia is the largest segment in Japan Sarcopenia Treatment Market to 2032 with a revenue of 90.67 USD Million in the year 2024.
- Primary Sarcopenia is the Fastest growing segment in Japan Sarcopenia Treatment Market to 2032 with a Growth rate of 11.84 % in forecast period 2025-2032.
-
Japan Sarcopenia Treatment Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Japan Sarcopenia Treatment Market to 2032 with a revenue of 103.25 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Japan Sarcopenia Treatment Market to 2032 with a Growth rate of 12.04 % in forecast period 2025-2032.
-
Japan Sarcopenia Treatment Market to 2032, By Stages
- Pre-Sarcopenia is the largest segment in Japan Sarcopenia Treatment Market to 2032 with a revenue of 68.04 USD Million in the year 2024.
- Pre-Sarcopenia is the Fastest growing segment in Japan Sarcopenia Treatment Market to 2032 with a Growth rate of 12.44 % in forecast period 2025-2032.
-
Japan Sarcopenia Treatment Market to 2032, By Route of Administration
- Oral is the largest segment in Japan Sarcopenia Treatment Market to 2032 with a revenue of 87.49 USD Million in the year 2024.
- Oral is the Fastest growing segment in Japan Sarcopenia Treatment Market to 2032 with a Growth rate of 12.00 % in forecast period 2025-2032.
-
Japan Sarcopenia Treatment Market to 2032, By Gender
- Male is the largest segment in Japan Sarcopenia Treatment Market to 2032 with a revenue of 94.25 USD Million in the year 2024.
- Male is the Fastest growing segment in Japan Sarcopenia Treatment Market to 2032 with a Growth rate of 11.69 % in forecast period 2025-2032.
-
Japan Sarcopenia Treatment Market to 2032, By End User
- Hospitals is the largest segment in Japan Sarcopenia Treatment Market to 2032 with a revenue of 83.76 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in Japan Sarcopenia Treatment Market to 2032 with a Growth rate of 12.31 % in forecast period 2025-2032.
Japan Sarcopenia Treatment Market Company Share Analysis
| Company Name |
|
||
| Nestlé | |||
| Novartis AG | |||
| Sanofi | |||
| BASF SE | |||
| Abbott | |||
Japan Sarcopenia Treatment Market Geographical Sales Distribution, 2018-2032 USD Million
Japan Sarcopenia Treatment Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Japan Sarcopenia Treatment Market is segmented based on Segmentation Treatment Type,Type,Distribution Channel,Stages,Route of Administration,Gender,End User.
Japan Sarcopenia Treatment Market was valued at USD 143.53(Revenue in USD Million) in 2021.
Japan Sarcopenia Treatment Market is projected to grow at a CAGR of 11.20% during the forecast period of 2024 to 2032.
The Direct Tender segment is expected to dominate the Japan Sarcopenia Treatment Market, holding a largest market share of 103.25 USD Million in 2024
Japan Sarcopenia Treatment Market Scope
Japan Sarcopenia Treatment Market Segmentation & Scope
Treatment Type
- Others
- Medications1
- Vitamin/Dietary Supplements1
Type
- Secondary Sarcopenia
- Primary Sarcopenia
Distribution Channel
- Others
- Retail Sales
- Direct Tender
Stages
- Severe Sarcopenia
- Sarcopenia
- Pre-Sarcopenia
Route of Administration
- Others
- Injectables
- Oral
Gender
- Female
- Male
End User
- Others
- Home Healthcare
- Speciality Clinics
- Hospitals
Frequently Asked Questions
The Japan Sarcopenia Treatment Market is segmented based on Segmentation Treatment Type,Type,Distribution Channel,Stages,Route of Administration,Gender,End User.
Japan Sarcopenia Treatment Market was valued at USD 143.53(Revenue in USD Million) in 2021.
Japan Sarcopenia Treatment Market is projected to grow at a CAGR of 11.20% during the forecast period of 2024 to 2032.
The estimated market value of the Japan Sarcopenia Treatment Market for final year is USD 262.28 (USD Million).
Japan Sarcopenia Treatment Market Company Profiling
Frequently Asked Questions
The Japan Sarcopenia Treatment Market is segmented based on Segmentation Treatment Type,Type,Distribution Channel,Stages,Route of Administration,Gender,End User.
Japan Sarcopenia Treatment Market was valued at USD 143.53(Revenue in USD Million) in 2021.
Japan Sarcopenia Treatment Market is projected to grow at a CAGR of 11.20% during the forecast period of 2024 to 2032.
The estimated market value of the Japan Sarcopenia Treatment Market for final year is USD 262.28 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.